None

Скачать статью в PDF
DOI: https://doi.org/None
Номер журнала: 
2
Год издания: 
2017

None

None
Ключевые слова: 
None
Для цитирования: 
None None . Фармация, 2017; 66 (2): 51-54
Список литературы: 
  1. Nemirovsky A., Niv D. Cholinergic Mechanisms and antinociception. In Current Review of Pain. Edited by Gerald M. Aronoff, Winston C.V. Parris, Ronald P. Pawl, P. Prithvi Raj: Current Science, Inc., 1996; 1 (1), 10–22.
  2. Detweiler D.J., Eisenach J.C., Tong C., Jackson C. A cholinergic interaction in alpha sub 2 adrenoceptor-mediated antinociception in sheep. J. Pharmacol. Exp. Ther., 1993; 265: 536–42.
  3. Bouaziz H., Hewitt C., Eisenach J.C. Spinal neostigmine potentiation of alpha sub 2-adrenergic agonist analgesia: dexmedetomidine versus clonidine. Reg. Anesth., 1995 in press.
  4. Zhuo M., Gebhart G.F. Tonic cholinergic inhibition of spinal mechanical transmission. Pain, 1991; 46: 211–20.
  5. Bouaziz H., Tong C., Eisenach J.C. Postiperative analgesia from intrathecal neostigmine in sheep. Anesthesia & Analgesia, 1995; 80: 1140–4.
  6. Eisenach J.C., Detweiler D.J., Tong C., D’Angelo R., Hood D.D. Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesthesia & Analgesia, 1996; 82: 621–6.
  7. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 1988; 32: 77–88.
  8. Kraus E., Besson J.M., Le Bars D. Behavioral model for diffuse noxious inhibitory controls (DNIC): potentiation by 5-hydroxytryptophan. Brain Research, 1982; 231 (2): 461–5.
  9. Cadden S.W., Villanueva L., Chitour D., Le Bars D. Depression of activities of dorsal horn convergent neurons by propriospinal mechanisms triggered by noxious input; comparison with diffuse noxious inhibitory controls (DNIC). Brain Research, 1983; 275 (1): 1–11.
  10. Bouhassira D., Villanueva L., Bing Z., Le Bars D. Involvement of the subnucleus reticularis dorsalis in diffuse noxious inhibitory controls in rat. Brain Research, 1992; 595 (2): 353–7.
  11. Alyautdin R.N., Romanov B.K. Inverse agonists: more than antagonists? On the safety of acetaminophen. Safety and Risk of Pharmacotherary 2014; 4, 6–11.
  12. Bouhassira D., Bing Z., Le Bars D. Studies of brain structures involved in diffuse noxious inhibitory controls in the rat: the rostral ventromedial medulla. Journal of Physiology, 1993; 463: 667–87.
  13. Morgan M.M., Gogas K.R., Basbaum A.I. Diffuse noxious inhibitory controls reduce the expression of noxious stimulus-evoked Fos-like immunoreactivity in the superficial and deep laminae of the rat spinal cord. Pain, 1994; 56 (3): 347–52.
  14. Zhuo M., Gebhart G.F. Inhibition of a cutaneous nociceptive reflex by a noxious visceral stimulus is mediated by spinal cholinergic and descending serotonergic systems in the rat. Brain Research, 1992; 585 (1–2): 7–18.
  15. Morton C.R., Maisch B., Zimmermann M. Diffuse noxious inhibitory controls of lumbar spinal neurons in volve a supraspinal loop in the cat. Brain Research, 1987; 410 (2): 347–52.
  16. Le Bars D., Villanueva L., Bouhassira D., Willer J.C. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patologicheskaia Fiziologiia I Eksperimentalnaia Terapiia, 1992; 4: 55–65.
  17. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurons in the rat. Pain, 1979; 6 (3): 283–304.
  18. Chitour D., Dickenson A.H., Le Bars D. Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Research, 1982; 236 (2): 329–37.
  19. Men D.S., Matsui Y. Activation of descending noradrenergic system by peripheral nerve stimulation. Brain Research Bulletin, 1994; 34 (3): 177–182.
  20. Peters M.L., Schmidt A.J., Van den Hout M.A., Koopmans R., Sluijter M.E. Chronic back pain, acute postoperative pain and the activation of diffuse noxious inhibitory controls (DNIC). Pain, 1992; 50 (2): 177–87.
  21. Lewis J.W., Cannon J.T., Liebeskind J.C. Involvement of central muscarinic cholinergic mechanisms in opioid stress analgesia. Brain Res., 1983; 270: 289–293.
  22. MacLennan A.J., Drugan R.C., Maier S.F. Long-term stress-induced analgesia blocked by scopolamine. Psychopharmacology, 1983; 80: 267–8.
  23. Mayer D.J., Watkins L.R. Multiple endogenous opiate and nonopiate analgesia systems. Adv. Pain. Res. Ther. 1984, 6: 253–76.
  24. Terman G.W., Shavit Y., Lewis J.W. et al. Intrinsic mechanisms of pain inhibition and their activation by stress. Science, 1984; 226:1270–7.
  25. Alyautdin R.N., Romanov B.K., Lepakhin et al. On the safety of acetaminophen. Safety and Risk of Pharmacotherary, 2014; 2: 5–9.
  26. Watkins L.R., Katayama Y., Kinscheck I.B. et al. Muscarinic cholinergic mediation of opioid and non-opioid environmentally induced analgesia. Brain Res., 1984; 300: 231–42.
  27. Sperber E.S., Kramer E., Bodnar R.J. Effects of muscarinic receptor antagonism upon two forms of stress-induced analgesia. Pharmacol. Biochem. Behav., 1986; 25:171–9.
  28. Katayama Y., Watkins L.R., Becker D.P. et al. Evidence for involvement of cholinoceptive cells of the parabrachial region in environmentally induced nociceptive suppression in the cat. Brain Res., 1984; 299: 348–53.